A new trading day began on Monday, with GoodRx Holdings Inc (NASDAQ: GDRX) stock price down -2.55% from the previous day of trading, before settling in for the closing price of $4.71. GDRX’s price has ranged from $4.09 to $9.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 26.70% over the last five years. Meanwhile, its annual earnings per share averaged 22.50%. With a float of $86.74 million, this company’s outstanding shares have now reached $103.93 million.
The firm has a total of 694 workers. Let’s measure their productivity. In terms of profitability, gross margin is 84.0%, operating margin of 5.82%, and the pretax margin is -0.58%.
GoodRx Holdings Inc (GDRX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of GoodRx Holdings Inc is 77.24%, while institutional ownership is 18.01%. The most recent insider transaction that took place on Dec 02 ’24, was worth 471,451. Before that another transaction happened on Sep 03 ’24, when Company’s 10% Owner sold 10,677 for $7.86, making the entire transaction worth $83,922. This insider now owns 0 shares in total.
GoodRx Holdings Inc (GDRX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 22.50% per share during the next fiscal year.
GoodRx Holdings Inc (NASDAQ: GDRX) Trading Performance Indicators
Here are GoodRx Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.22. Likewise, its price to free cash flow for the trailing twelve months is 11.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of GoodRx Holdings Inc (GDRX)
Analysing the last 5-days average volume posted by the [GoodRx Holdings Inc, GDRX], we can find that recorded value of 0.83 million was lower than the volume posted last year of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 18.16%. Additionally, its Average True Range was 0.21.
During the past 100 days, GoodRx Holdings Inc’s (GDRX) raw stochastic average was set at 9.85%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.65% in the past 14 days, which was lower than the 63.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.57, while its 200-day Moving Average is $7.05. Now, the first resistance to watch is $4.70. This is followed by the second major resistance level at $4.81. The third major resistance level sits at $4.87. If the price goes on to break the first support level at $4.54, it is likely to go to the next support level at $4.48. Should the price break the second support level, the third support level stands at $4.37.
GoodRx Holdings Inc (NASDAQ: GDRX) Key Stats
With a market capitalization of 1.75 billion, the company has a total of 381,142K Shares Outstanding. Currently, annual sales are 750,270 K while annual income is -8,870 K. The company’s previous quarter sales were 195,250 K while its latest quarter income was 3,970 K.
